The Institute for Protein Innovation (IPI) is a nonprofit research institute with a mission to advance protein science and improve human health. They are pioneering a new approach to scientific discovery and collaboration by providing the biomedical research community with synthetic antibodies and deep protein expertise. At the core of IPI is their cutting-edge platform, which combines state-of-the-art technology and skilled scientists from top institutions worldwide.

They use yeast display technology to produce high-quality synthetic recombinant antibodies, overcoming the limitations of traditional antibodies and reducing cross-reactivity in downstream research. These critical protein tools empower scientists to explore fundamental biological processes and identify new targets for therapeutic development. IPI's Receptor Engineering group specializes in tackling hard-to-reach antibodies, providing key reagents for research and therapeutic development.

They invest in people with expertise and creativity, encouraging a fresh perspective on scientific questions. Since its establishment, IPI has made significant strides in protein research and innovation. They are located at the Harvard Medical School campus and have a team of dedicated scientists driving their mission forward.

Contact IPI today to join their journey towards advancing protein science and improving human health